Relmada Therapeutics Inc. (RLMD): Former FDA CRO said recently ‘judging fr...

Next 10 Prev Next

Send PM Follow Ignore

Followers	10
Posts	605
Boards Moderated	0
Alias Born	06/30/2014

VictorMasonIsRight

Re: None

Wednesday, 06/17/2020 6:36:18 AM

Wednesday, June 17, 2020 6:36:18 AM

Former FDA CRO said recently ‘judging from the quality of the people they’re hiring RLMD looks like they are playing the long game’ meaning they are gearing up to take REL 1017 to approval not selling out

RTW Investments filed 13G showing additional 271.13K shares of RLMD purchased. Brings them up to 1.26M 8.26%

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RLMD News

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/13/2026 08:53:07 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:05:56 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/04/2026 08:25:12 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:31:38 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2026 08:30:44 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/10/2026 04:15:17 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/09/2026 08:20:40 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 08:35:14 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/03/2026 08:30:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:52:59 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:25:32 PM
Relmada Therapeutics shares jump 25% after promising bladder cancer trial results • IH Market News • 03/09/2026 01:51:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:11:01 AM
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (Canada) • 02/26/2026 05:07:00 PM
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (US) • 02/26/2026 05:07:00 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 02:15:23 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2026 10:14:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:29:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:28:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 12:50:18 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent RLMD News

More RLMD News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent RLMD News

Go Ad-Free